Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Short term Debt (2016 - 2025)

Surgery Partners' Short term Debt history spans 12 years, with the latest figure at $99.3 million for Q4 2025.

  • For Q4 2025, Short term Debt fell 2.07% year-over-year to $99.3 million; the TTM value through Dec 2025 reached $99.3 million, down 2.07%, while the annual FY2025 figure was $99.3 million, 2.07% down from the prior year.
  • Short term Debt for Q4 2025 was $99.3 million at Surgery Partners, down from $103.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $116.9 million in Q3 2022 and bottomed at $60.4 million in Q4 2021.
  • The 5-year median for Short term Debt is $71.4 million (2021), against an average of $80.8 million.
  • The largest annual shift saw Short term Debt skyrocketed 92.27% in 2022 before it tumbled 46.88% in 2023.
  • A 5-year view of Short term Debt shows it stood at $60.4 million in 2021, then rose by 3.97% to $62.8 million in 2022, then increased by 16.72% to $73.3 million in 2023, then skyrocketed by 38.34% to $101.4 million in 2024, then decreased by 2.07% to $99.3 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Short term Debt are $99.3 million (Q4 2025), $103.0 million (Q3 2025), and $110.0 million (Q2 2025).